2017
DOI: 10.1016/j.bios.2016.11.004
|View full text |Cite
|
Sign up to set email alerts
|

Label-free piezoelectric biosensor for prognosis and diagnosis of Systemic Lupus Erythematosus

Abstract: An autoantigen piezoelectric sensor to quantify specific circulating autoantibodies in human serum is developed. The sensor consisted on a quartz crystal microbalance with dissipation monitoring (QCM-D) where TRIM21 and TROVE2 autoantigens were covalently immobilized, allowing the selective determination of autoantibodies for diagnosis and prognosis of Systemic Lupus Erythematosus (SLE). The sensitivity of the biosensor, measured as IC value, was 1.51U/mL and 0.32U/mL, for anti-TRIM21 and anti-TROVE2 circulati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1
1

Relationship

2
8

Authors

Journals

citations
Cited by 38 publications
(17 citation statements)
references
References 24 publications
0
17
0
Order By: Relevance
“…The paper-based discs are disposable while the PCB substrate can be reused. In comparison to other rapid, sensitive and portable label-free biosensors for protein quantification that have recently been reported in the literature [16][17][18][19][20][21][22][23][24][25][26][27][28], the presented method has improved cost-effectiveness, simplification and ease of use. Thus, although an increased upper limit of detection for our presented methodology is suspected, further research should be carried out to determine whether it may be applicable for the measurement of protein biomarkers of a broadened range of concentrations.…”
Section: Analysis and Comparison With Elisa And Recently Developed Mementioning
confidence: 97%
“…The paper-based discs are disposable while the PCB substrate can be reused. In comparison to other rapid, sensitive and portable label-free biosensors for protein quantification that have recently been reported in the literature [16][17][18][19][20][21][22][23][24][25][26][27][28], the presented method has improved cost-effectiveness, simplification and ease of use. Thus, although an increased upper limit of detection for our presented methodology is suspected, further research should be carried out to determine whether it may be applicable for the measurement of protein biomarkers of a broadened range of concentrations.…”
Section: Analysis and Comparison With Elisa And Recently Developed Mementioning
confidence: 97%
“…They should fundamentally comprise a transducer (electrochemical [78], piezoelectric [79], or optical [80]) and a recognition molecule, which interacts with an analyte. A number of optical sensing studies have been performed on sensors involving chemiluminescence [81], fluorescence [82], light absorption [83], and reflectance [84] that can be classified as label-based and label-free.…”
Section: Macromolecular Imprinted Sensorsmentioning
confidence: 99%
“…Sensitive and accurate biosensing systems for these biomarkers can not only significantly aid in the early diagnosis and clinical management of AIDs but also help to establish therapeutic strategies [ 4 ]. Biosensors for the detection of autoantibodies specific to AIDs, including antiphospholipid syndrome (APS) [ 91 , 92 , 93 , 94 ], rheumatoid arthritis (RA) [ 95 , 96 , 97 , 98 , 99 ], systemic lupus erythematosus (SLE) [ 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 ], multiple sclerosis (MS) [ 108 , 109 , 110 , 111 ], and celiac disease (CD) [ 112 , 113 , 114 , 115 , 116 , 117 , 118 , 119 , 120 , 121 , 122 , 123 , 124 ], are now constructed based on diverse techniques with many advantages, including high sensitivity and easy operation.…”
Section: Potential Applications Of Antibody Biosensing For Clinicamentioning
confidence: 99%